• Skip to primary navigation
  • Skip to main content
ALS Untangled®
  • How to Use
  • Mission & Methods
  • Completed Reviews
  • Future Reviews
  • Search
  • English
    • English
    • Español

Search ALS Untangled®

Patient case reports

Ashwagandha

February 13, 2024

WS appears reasonably safe, has plausible mechanisms by which it might slow ALS progression, and has promising data obtained in multiple different clinical models of ALS. While there are also some interesting self reports from PALS and one verified ALS reversal on a compound containing WS, these must be interpreted with caution because of the […]

Astaxanthin

January 25, 2023

There are theoretical mechanisms supporting the potential role of astaxanthin in the treatment of ALS, however, there are no ALS specific preclinical data exploring this treatment. One verified “ALS reversal” occurred while taking astaxanthin in the setting of a cocktail of various other therapies an association that does not prove causality. There have been no […]

Ozone

November 21, 2022

Ozone therapy has possible mechanisms for treating ALS. A preclinical study in very small numbers of mTDP43 mice (which has yet to be peerreviewed) suggested benefits on motor function and survival (21,22); however, these benefits were not seen in mSOD1 mice (20). One verified “ALS reversal” occurred on a cocktail of alternative therapies including ozone […]

Butyrates

March 21, 2022

Butyrates have plausible mechanisms for slowing ALS progression and positive pre clinical studies. One trial suggests that sodium phenylbutyrate (NaPB) in combination with Tauroursodeoxycholic acid (TUDCA) can slow ALS progression and prolong survival, but the specific contribution of NaPB toward this effect is unclear. Butyrates appear reasonably safe for use in humans. Based on the […]

Tamoxifen

February 1, 2021

Tamoxifen is reasonably safe, has plausible mechanisms for treating ALS, and has at least one positive preclinical study. One case report and 2 small human trials suggested an association between tamoxifen (at higher doses) and slower ALS progression but this is not enough evidence to recommend this medication as an ALS treatment. Moving forward, we […]

RCH4

October 10, 2019

RCH4 is an unlicensed, unapproved product reported to “probably slow the progression of your ALS” (6) on a website. The only peer reviewed publication we found on this product is a single abstract which was never presented at a meeting. We have been unable to determine RCH4’s structure or chemical class, and its purported mechanism […]

Resveratrol

April 4, 2019

Resveratrol is a dietary supplement that likely activates SIRT1 cellular pathways and may alter the gut microbiome. These are interesting mechanisms that may potentially alter the progression of ALS and do confer benefit in animal models of one type of familial ALS; however, to-date, there have been no trials of resveratrol in PALS. Some trials […]

Hyperbaric Oxygen

October 17, 2016

Although there are plausible mechanisms by which HBOT could work in ALS and a flawed pre-clinical study showing benefit in a mouse model, the best available human trial of HBOT showed no benefit. Given this negative human trial and the fact that HBOT has potentially serious complications, we do not recommend HBOT for patients with […]

  • Page 1
  • Page 2
  • Go to Next Page »
© 2025 ALS Untangled® · All rights reserved · Website by Code the Dream & Tomatillo Design
Search ALS Untangled®